Response to Letter Regarding Article, "The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio"

M. J. Brown, S. J. Hood, M. J. Ashby, K. P. Taylor
2008 Circulation  
Reference 1. Hood S, Cannon J, Foo R, Brown M. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
doi:10.1161/circulationaha.107.744250 fatcat:ktcafz5b6zgwllrqm47dgo6v5y